CIBC Bancorp USA’s Aehr Test Systems AEHR Stock Holding History

CIBC Bancorp USA’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$371K	Buy	+3,364	New	+$307K	﹤0.01%	1433

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Bancorp USA's AEHR Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 3,364 shares worth $371K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings.

245 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

CIBC Bancorp USA held 3,364 shares of Aehr Test Systems worth $371K as of Q2 2026.
Aehr Test Systems was a new CIBC Bancorp USA position in Q2 2026.
Aehr Test Systems made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1433 holding.
245 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.